| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1104514850 |
| P356 | DOI | 10.1186/S40170-018-0180-9 |
| P932 | PMC publication ID | 5996481 |
| P698 | PubMed publication ID | 29942509 |
| P50 | author | Rainer J. Klement | Q56073415 |
| Cholpon S Djuzenova | Q106869808 | ||
| Ulrike Kämmerer | Q115216455 | ||
| P2093 | author name string | Achim Wöckel | |
| Christoph Otto | |||
| Michaela Kapp | |||
| Catharina Bartmann | |||
| Almut Schulze | |||
| Jessica Flöter | |||
| Jana Willingstorfer | |||
| Katrin Bahlke | |||
| Maria Strunz | |||
| Sudha R Janaki Raman | |||
| P2860 | cites work | Is there a role for carbohydrate restriction in the treatment and prevention of cancer? | Q21245058 |
| Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism | Q24611305 | ||
| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Q24647928 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion | Q26801473 | ||
| Hyperglycemia as a risk factor for cancer progression | Q27687614 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma | Q28730187 | ||
| On respiratory impairment in cancer cells | Q29617276 | ||
| Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
| Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report | Q33562229 | ||
| ERGO: a pilot study of ketogenic diet in recurrent glioblastoma | Q33778107 | ||
| A meta-analysis between dietary carbohydrate intake and colorectal cancer risk: evidence from 17 observational studies | Q33792682 | ||
| Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes | Q33817233 | ||
| Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival. | Q51632004 | ||
| A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma. | Q52145569 | ||
| Need for new review of article on ketogenic dietary regimes for cancer patients. | Q53326526 | ||
| The inhibition of malignant cell growth by ketone bodies | Q53580986 | ||
| Effects of Pre-surgical Vitamin D Supplementation and Ketogenic Diet in a Patient with Recurrent Breast Cancer. | Q54243956 | ||
| In vitro chemoresponse assay based on the intrinsic subtypes in breast cancer. | Q54354615 | ||
| Cell biology. Cases of mistaken identity. | Q55043245 | ||
| Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells. | Q55056276 | ||
| The ketogenic diet and epilepsy | Q56431461 | ||
| Benefit of taxanes as adjuvant chemotherapy for early breast cancer | Q61899631 | ||
| Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements | Q70168020 | ||
| -Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay- | Q71118678 | ||
| Cell biology. When 60 lines don't add up | Q79782593 | ||
| Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44 | Q33824543 | ||
| Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy | Q33972116 | ||
| Glutamine addiction: a new therapeutic target in cancer | Q34050094 | ||
| Ketone bodies, potential therapeutic uses | Q34092390 | ||
| Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia | Q34193811 | ||
| Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival | Q34194681 | ||
| Ketoacids? Good medicine? | Q34206876 | ||
| The monocarboxylate transporter family--Structure and functional characterization | Q34237222 | ||
| Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy | Q34275617 | ||
| Ketone body utilization drives tumor growth and metastasis | Q34307146 | ||
| Role of glucose and ketone bodies in the metabolic control of experimental brain cancer | Q34542313 | ||
| Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. | Q34558255 | ||
| Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. | Q34591316 | ||
| Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports | Q34722625 | ||
| Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma | Q34749380 | ||
| The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer | Q34766593 | ||
| History of the ketogenic diet | Q34892581 | ||
| Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential | Q35000248 | ||
| Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics | Q35051171 | ||
| Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial | Q35168645 | ||
| Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer | Q35390899 | ||
| β-hydroxybutyrate: much more than a metabolite | Q35553084 | ||
| Effect of ketogenic Mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees | Q35554856 | ||
| Choosing the right cell line for breast cancer research | Q35608671 | ||
| TKTL1 expression in human malign and benign cell lines. | Q35695409 | ||
| Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. | Q35897181 | ||
| Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients | Q35946704 | ||
| Dietary Patterns in Puerto Rican and Mexican-American Breast Cancer Survivors: A Pilot Study | Q35960080 | ||
| Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis. | Q36012197 | ||
| High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer | Q36190132 | ||
| Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester | Q36197639 | ||
| Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial | Q36257907 | ||
| Ketone-body metabolism in glioma and neuroblastoma cells | Q36380716 | ||
| Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes | Q43794368 | ||
| Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients | Q44266484 | ||
| Monocarboxylate transporters in subsarcolemmal and intermyofibrillar mitochondria | Q45047338 | ||
| Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials | Q45335146 | ||
| Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping | Q47100468 | ||
| The influence of ketogenic therapy on the 5 R's of radiobiology. | Q47987478 | ||
| Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth | Q47992732 | ||
| Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells | Q36426491 | ||
| The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice | Q36502310 | ||
| Fuel metabolism in starvation | Q36539491 | ||
| Pre-diagnosis blood glucose and prognosis in women with breast cancer. | Q36769486 | ||
| Correlation between the molecular subtype of breast cancer and the in vitro adenosine triphosphate-based chemosensitivity assay | Q36897666 | ||
| Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss | Q36981946 | ||
| The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model | Q37173979 | ||
| Monocarboxylate transporters in the brain and in cancer. | Q37187094 | ||
| Long-term effects of a ketogenic diet in obese patients | Q37277823 | ||
| Long term successful weight loss with a combination biphasic ketogenic Mediterranean diet and Mediterranean diet maintenance protocol | Q37420487 | ||
| UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. | Q37519690 | ||
| Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts | Q37637990 | ||
| Impact of a 6-week non-energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in healthy adults | Q37655212 | ||
| The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradox | Q37673340 | ||
| Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme | Q38179992 | ||
| Mitochondria: The ketogenic diet--A metabolism-based therapy | Q38349844 | ||
| Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature | Q38389958 | ||
| Continued value of adjuvant anthracyclines as treatment for early breast cancer. | Q38543409 | ||
| Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities. | Q38693843 | ||
| Molecular characterization of breast cancer cell lines through multiple omic approaches. | Q38701221 | ||
| Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics | Q38723509 | ||
| Measurement and Analysis of Extracellular Acid Production to Determine Glycolytic Rate. | Q38808562 | ||
| Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. | Q38929108 | ||
| Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer | Q39234566 | ||
| The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines | Q39669204 | ||
| Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts. | Q39683758 | ||
| Ketone bodies inhibit the viability of human neuroblastoma cells. | Q39892401 | ||
| Breast cancer statistics, 2015: Convergence of incidence rates between black and white women | Q40379855 | ||
| Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency | Q40522316 | ||
| Association between dietary carbohydrate intake, glycemic index and glycemic load, and risk of gastric cancer | Q40912478 | ||
| Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival | Q41517836 | ||
| Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. | Q41550485 | ||
| Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer. | Q41555731 | ||
| The contributions of respiration and glycolysis to extracellular acid production | Q41755837 | ||
| The effects of a ketogenic diet on exercise metabolism and physical performance in off-road cyclists | Q41866154 | ||
| Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy | Q41895412 | ||
| Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System | Q42360015 | ||
| Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition | Q42364281 | ||
| High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation | Q42461741 | ||
| The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells | Q42756576 | ||
| Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes | Q42994129 | ||
| Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis | Q43508615 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8 | |
| P577 | publication date | 2018-06-11 | |
| P1433 | published in | Cancer & Metabolism | Q27724831 |
| P1476 | title | Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. | |
| P478 | volume | 6 |
| Q93376845 | Beta-Hydroxybutyrate Promotes Proliferation, Migration and Stemness in a Subpopulation of 5FU Treated SW480 Cells: Evidence for Metabolic Plasticity in Colon Cancer |
| Q90699675 | Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer |
| Q92533012 | Ketogenic diet in the treatment of cancer - Where do we stand? |
| Q93048857 | Lithium and Not Acetoacetate Influences the Growth of Cells Treated with Lithium Acetoacetate |
| Q97525205 | Metabolic Adaptations in Cancer Stem Cells |
| Q92669550 | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
| Q64290756 | Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma |
| Q64905264 | Wilhelm Brünings' forgotten contribution to the metabolic treatment of cancer utilizing hypoglycemia and a very low carbohydrate (ketogenic) diet. |
Search more.